热门资讯> 正文
TG Therapeutics在收购猜测中上涨
2026-08-21 22:01
- TG Therapeutics (TGTX) jumped 7.2% amid renewed takeover speculation.
- TG Therapeutics (TGTX) may have attracted new takeover interest from an unnamed suitor, according to traders, who cited a Betaville “uncooked” alert that was circulating on Friday. The potential buyer is speculated to be a U.S.-listed biopharma with a market cap between $20 billion and $40 billion.
- Betaville reported in 2019 that TG (TGTX) was at the center of takeover speculation and that Jazz Pharmaceuticals (JAZZ) may have been one of the companies interested.
More on TG Therapeutics
- TG Therapeutics: Why I'm Staying Long After The Q2 Selloff
- TG Therapeutics, Inc. (TGTX) Q2 2026 Earnings Call Transcript
- TG Therapeutics Surged 88%: Time To Be More Careful (Rating Downgrade)
- SA Asks: What's the outlook for Big Pharma M&A?
- TG Therapeutics down 11% following Q2 bottom line miss
推荐文章
美股盘前 | 业绩股齐跌！迈威尔科技、IREN均大跌逾8%；Stripe财团拟放弃对PayPal收购
美股前瞻 | 英伟达强劲指引"炸场"！绩后大涨6%，带动存储、光通信齐冲高；美国酝酿半导体新关税；Modema将发行巨额可转债
70%增长不是天花板！英伟达首次抛出远期指引，AI Factory下一波红利流向哪里？
全文|英伟达Q2业绩会实录：内存涨价超出预期 不怕合作伙伴竞争
财报和电话会两重天 英伟达投资者和股价跟着AI展望一起坐过山车
Meta与美国多州就社交媒体危害案达成和解 最高将支付约180亿美元
迪克体育用品股价暴跌，暴露出陷入困境的耐克面临一大核心难题
杰克逊霍尔年会前夕：美元、债市高度紧绷，贝森特市场干预给沃什施加巨大压力
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
